Anticoagulants Market: Unlocking the Potential of Blood-Thinning Therapies

The global anticoagulants market is witnessing significant growth attributed to the increasing prevalence of coagulation disorders and thrombotic complications, especially among patients affected by COVID-19. This article presents an in-depth analysis of the market dynamics, including key insights, trends, and forecasts for the period 2022-2031.

The global anticoagulants market was valued at US$ 30.7 billion in 2021, with a projected CAGR of 6.2% from 2022 to 2031. By the end of 2031, the market is expected to surpass US$ 56.6 billion, driven by factors such as the rise in cases of coagulation disorders, strategic alliances among leading companies, and an increase in hip and knee surgeries.

Don't miss out on essential insights - Get your sample copy now: 

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=60924

Driving Factors:

a. Coagulation Disorders and Thrombotic Complications: The increasing prevalence of coagulation disorders, coupled with thrombotic complications in COVID-19 patients, is driving the demand for anticoagulants worldwide.

b. Geriatric Population and Obesity: The surge in the geriatric population and the rise in obesity rates are contributing to the growth of the anticoagulants market, as these demographic groups are more prone to thrombotic events.

c. Strategic Alliances and Market Expansion: Leading companies are forming strategic alliances to increase product penetration, particularly in developing countries like India, China, and Brazil, thereby expanding their market presence.

Types of Anticoagulants:

Anticoagulants are available in various forms, including factor XA inhibitors (NOAC/DOAC), heparins, direct thrombin inhibitors, and vitamin K antagonists. Factor XA inhibitors accounted for a major share of the global market in 2021, owing to their effectiveness in preventing thrombin formation.

Indications:

The market is segmented based on indications such as deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation & heart attack, ischemic stroke, and others. The atrial fibrillation & heart attack segment dominated the market in 2021, driven by the high prevalence of these conditions worldwide.

Route of Administration:

Anticoagulants can be administered orally or through injections. The oral segment constituted the largest share of the market in 2021, with direct oral anticoagulants (DOACs) gaining popularity due to their convenience and effectiveness.

Distribution Channels:

The market is segmented based on distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies dominated the market in 2021, driven by the increasing adoption of minimally invasive procedures and surgeries.

Place an Order Copy of Anticoagulants Market Report at: 

https://www.transparencymarketresearch.com/checkout.php?rep_id=60924<ype=S

Regional Analysis:

North America led the global anticoagulants market in 2021, attributed to the high incidence of orthotic conditions among the elderly population. However, Asia Pacific is projected to witness significant growth during the forecast period, driven by increasing awareness and improvements in healthcare infrastructure.

Key Players and Developments:

Prominent players in the global anticoagulants market include Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb, Daiichi Sankyo Company, Sanofi, Johnson & Johnson, and Pfizer, Inc. Key developments such as product launches and collaborations are shaping the competitive landscape of the market.

More Trending Reports by Transparency Market Research -

Biometrics Market

https://www.globenewswire.com/en/news-release/2022/08/02/2490352/0/en/Biometrics-Market-Size-worth-136-18-Billion-by-2031-CAGR-13-3-Notes-TMR-Study.html

Cardiac Output Monitoring Devices Market

https://www.globenewswire.com/en/news-release/2022/07/29/2488822/0/en/Cardiac-Output-Monitoring-Devices-Market-Attracts-Profitable-Prospects-due-to-Rise-in-Demand-for-Less-invasive-Techniques-for-Cardiac-Output-and-Stroke-Volume-SV-Measurement-Notes-.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.